CIK 0001800315 · Non-accelerated filer<br>Smaller reporting company
Damora Therapeutics, Inc.
Sign in to watch- Ticker
- DMRA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 371957007
- Phone
- (781) 281-9020
- Business address
- 100 FIFTH AVENUE, SUITE 700, WALTHAM, MA, 02451
- Former names
- Galecto, Inc., Galecto Inc.
- Open-market buys, last 90 days
- $252,875
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$252,875. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-05 | Sattarzadeh Sherwin Chief Operating Officer | Grant or award · Stock Option (right to buy) | +444,209 | 444,209 | ||
| 2026-01-05 | Hewes L. Becker Chief Medical Officer | Grant or award | +264,629 | 264,629 | ||
| 2026-01-05 | Hewes L. Becker Chief Medical Officer | Grant or award · Stock Option (right to buy) | +528,603 | 528,603 | ||
| 2026-01-02 | Schambye Hans T. Chief Executive Officer | Option exercise | +1,360 | 5,382 | ||
| 2026-01-02 | Schambye Hans T. Chief Executive Officer | Sale | −700 | $21.38 | $15K | 4,682 |
| 2026-01-02 | Schambye Hans T. Chief Executive Officer | Option exercise · Restricted Stock Units | −1,360 | 2,640 | ||
| 2026-01-02 | Winslow Garrett General Counsel | Option exercise | +680 | 2,109 | ||
| 2026-01-02 | Winslow Garrett General Counsel | Sale | −255 | $21.38 | $5K | 1,854 |
| 2026-01-02 | Winslow Garrett General Counsel | Option exercise · Restricted Stock Units | −680 | 1,320 | ||
| 2026-01-02 | Firmani Lori Chief Financial Officer | Option exercise | +374 | 1,066 | ||
| 2026-01-02 | Firmani Lori Chief Financial Officer | Sale | −135 | $21.41 | $3K | 931 |
| 2026-01-02 | Firmani Lori Chief Financial Officer | Option exercise · Restricted Stock Units | −374 | 726 | ||
| 2025-07-03 | Schambye Hans T. Chief Executive Officer | Option exercise | +1,360 | 4,757 | ||
| 2025-07-03 | Schambye Hans T. Chief Executive Officer | Sale | −735 | $3.38 | $2K | 4,022 |
| 2025-07-03 | Schambye Hans T. Chief Executive Officer | Option exercise · Restricted Stock Units | −1,360 | 4,000 | ||
| 2025-07-03 | Winslow Garrett General Counsel | Option exercise | +680 | 1,689 | ||
| 2025-07-03 | Winslow Garrett General Counsel | Sale | −260 | $3.39 | $881 | 1,429 |
| 2025-07-03 | Winslow Garrett General Counsel | Option exercise · Restricted Stock Units | −680 | 2,000 | ||
| 2025-07-03 | Firmani Lori Interim CFO | Option exercise | +374 | 839 | ||
| 2025-07-03 | Firmani Lori Interim CFO | Sale | −147 | $3.39 | $498 | 692 |
Page 2 of 12 · 227 trades